In a recent episode of the widely respected podcast "This Week in Virology" (TWiV), Dr. Daniel Griffin, a clinical expert,…
Read More
Keith J. Gray’s conviction underscores rising enforcement and audit risk as Medicare spending shifts toward high-cost genetic testing.
A federal jury in Dallas has delivered a resounding verdict, convicting Texas laboratory owner and former NFL player Keith J.…
Read More
FDA Rejects Moderna’s mRNA Flu Vaccine Application, Citing Comparator Study Flaws Amidst Broader Policy Shifts
Moderna, a leading biotechnology company, announced on Tuesday that the U.S. Food and Drug Administration’s (FDA) Center for Biologics Evaluation…
Read More
TWiV 1286: Clinical Update with Dr. Daniel Griffin Explores Alarming Shifts in Childhood Immunization and Enduring Public Health Challenges
In a recent clinical update on the "This Week in Virology" (TWiV) podcast, Dr. Daniel Griffin and host Vincent Racaniello…
Read More
Keith J. Gray’s conviction underscores rising enforcement and audit risk as Medicare spending shifts toward high-cost genetic testing.
A federal jury in Dallas has delivered a decisive verdict against Keith J. Gray, a 39-year-old Texas laboratory owner and…
Read More
Executive War College 2026 Speaker Spotlight Illuminates Path for Labs Navigating Reimbursement Pressures and Regulatory Shifts
The 2026 Executive War College on Diagnostics, Clinical Laboratory, and Pathology Management, scheduled for April 28-29 in New Orleans, is…
Read More
